A modification of the XC cell procedure for murine leukemia virus assay which yields quantitative data over a wide range of virus concentrations is described. By using serial passage of infected cell cultures and reversal of the plating sequence in the XC procedure, titers of radiation leukemia virus (RadLV) were obtained which were about 10-fold higher than those found by using the conventional assay. By using the modified procedure, it was observed that, even at high multiplicities of infection, less than 10% of the cells function as infective centers, although the proportion increases with serial passage. It was also observed that exposure of infected cells to UV light, which is commonly used to make plaques more visible in the conventional XC cell test, inhibits plaque formation in the RadLV system. Substitution of X irradiation for UV exposure improved plaque visibility without loss of sensitivity.
Radiation leukemia virus (RadLV) is consistently extractable from thymic lymphomas induced in strain C57BL mice by appropriate doses of whole-body X irradiation and may be serially propagated in vivo and extracted from the thymic lymphomas which it induces after inoculation into neonatal or infant C57BL/Ka mice (6, 7) . Unlike several of the other murine leukemia viruses, this virus has been notably difficult to propagate or assay in vitro.
About 3 years ago it became possible to assay RadLV by virtue of its helper function for the murine sarcoma virus, and focus assay techniques were successfully developed (2, 3) . However, in practice the focus assay proved complex and difficult to reproduce and was therefore not satisfactory for routine use. Recently the simpler and more reproducible plaque assay, based on syncytium formation by rat XC cells after contact with cells infected with murine leukemia viruses, was introduced by Rowe et al. (9) . Although we tried the XC cell assay in its originally reported form for the titration of RadLV, the titers observed with this technique proved to be relatively low, and the method was quite insensitive compared with the focus assay or with in vivo bioassay for the same preparations of virus. Accordingly, we have investigated and report herewith certain modifications of the XC cell assay which permit the determination of RadLV titers with greater sensitivity and reproducibility.
MATERIALS AND METHODS Tissue culture. All of the cell lines and mouse embryo fibroblast (MEF) cells were grown in complete medium (CM) composed of Eagle minimal essential medium (MEM) supplemented with 10% heat-inactivated fetal calf serum, penicillin (100 units/ml), streptomycin (100,ug/ml), and polymyxin (50 units/ml).
XC cells were kindly provided by A. J. Hackett of the Naval Biomedical Research Laboratory, Oakland, Calif. A continuous line of C57BL/Ka mouse embryo fibroblasts, designated BL-5, and the corresponding RadLV-infected subline, designated BL-5 (RadLV), were established in this laboratory and have been described elsewhere (8) . BL-3T3 cells were established recently from C57BL/Ka-MEF cells based on the procedure developed by Todaro and Green (11) . Secondary cultures of C57BL/Ka-MEF cells were prepared as described previously (2).
Virus. Wild-type preparations of RadLV were obtained from cell-free extracts of RadLV-induced lymphoma tissue by a previously described procedure (7) . Supernatant fluids of 3-day-old BL-5 (RadLV) cell cultures were used as the in vitro source of RadLV.
XC cell assay. Indicator cells (MEF, or BL-3T3) were plated in plastic petri dishes (50 mm) at a concentration of 2 x 105 cells per dish. After 24 h the culture fluid was removed, and the dishes were treated with 25 ,ug of DEAE-dextran per ml for 1 h at 37 C. Then the DEAE-dextran was removed, and the culture was infected with 0.2 ml of a virus-containing preparation. Serial dilutions of the virus were made in ice-cold CM with 4 ,g of Polybrene per ml (Abbott Laboratories) added. After adsorption for 2 h at 37 C, unattached virus was removed, the dishes were rinsed with MEM, and 5 ml of CM was added. Four days after infection, the dishes were irradiated with X rays or UV light, and 106 XC cells were added. Medium was replaced every 2 days. Plaque counts were determined on the fourth day after UV irradiation or the sixth day after X irradiation under lowpower microscope magnification.
Reverse Exposure of infected tissues to UV irradiation made the plaques much easier to see but sharply decreased the number of plaques as a function of UV dose (Fig. 1 ). There appeared to be two components to the slope of the curve for UV inactivation of plaque formation. Plaque number at a UV dose of 1,600 ergs/mm2 was only 10% that of the unirradiated control level. It was also observed that the UV-irradiated cells detached from the dishes within 24 h after irradiation.
Attention therefore turned to a study of the effect of X irradiation on the cultures. It was found that a dose of 10 krads yielded plaques which were more clearly delineated than those in the unirradiated control dishes, although not as clearly as the plaques seen after UV irradiation. However, in striking contrast to the effect of UV, X irradiation did not reduce the number UV DOSE (SEC) FIG. 1. Dose-response curve for UV inactivation of plaque formation by RadLV-infected cells in the XC cell assay. Mouse embryo fibroblast cells were infected with in vivo-derived RadLV. Four days after infection, the dishes were rinsed with saline and exposed to UV irradiation with a germicidal lamp at a dose rate of 14 ergs per mm2 per s. In this and all subsequent experiments, three plates per point were used. The average number of plaques per plate in the unirradiated samples was normalized to 100 to calculate relative plaque numbers in the UV-irradiated samples.
of plaques, and most of the cells in the Xirradiated dishes remained attached for at least 6 days after irradiation. Accordingly, X irradiation at a dose level of 10 krads, with inspection of the dishes at 6 days, became the routine procedure for conventional XC cell assays of RadLV. A less satisfactory altemative is to examine plaques at the third or fourth day after XC cell overlay without irradiation.
Plaque formation in the reverse XC cell assay. The infected cells were plated as an overlay on cultures of XC cells, the reverse of the usual sequence. Three to four days later, small, clear plaques composed of multinucleated giant cell syncytia were observed. There was a one-toone correlation between the number of infected cells and the number of plaques formed (Fig. 2) , indicating that 100% of BL-5 (RadLV) cells were infected with RadLV and served as infective centers. Plaque number was not affected by the addition of 105 uninfected BL-5 cells to the system at the time of overlay, suggesting that secondary plaque formation is not a significant problem. X irradiation of the BL-5 (RadLV) cells with a dose of 2 krads just before seeding on the XC cell layer did not affect their plaque- (Fig. 4) . The same data are plotted as a function of serial dilution through each passage 0.01 -in Fig. 5 . In the first passage, the percentage of -plaque-forming cells was a linear function of virus dilution, but the slope of the curve became progressively flatter through the third and 0.01 fourth passages when more than 10% of the cells Comparative sensitivity of the XC cell and the reverse XC cell assays. Typical titration curves for in vivo-derived RadLV on three 0 different cell lines, using the XC cell assay with A X irradiation as described above, are seen in . -\ Fig. 6 . The sensitivity of BL-3T3 cells was consistently about one decade lower than that au \ of either BL-5 or MEF cells.
Virus titers expressed in terms of PFU per 0.2 ml of input virus, as calculated from the titration curves of Fig. 6 , are listed in Table 1 (Fig. 7) . This observation is being studied in greater detail and will be described more fully in a later publication.
Conversely, the end-point dilution procedure using the reverse XC cell technique provided a more sensitive method for the detection of very small amounts of RadLV. However, relatively large statistical errors are inevitable with the end-point dilution titration, and thus a more quantitative and reliable assay is required for The fact that the end-point dilution titer observed by the reverse XC cell technique was consistently higher than the PFU titer obtained with the XC cell assay suggests that the reduction of plaque number after UV irradiation in the XC cell test was not due to prevention of satellite plaque formation but rather to interference by UV with the process of plaque formation. The Do value of the UV-sensitive component of the dose response curve (Fig. 1) is 616 ergs/mm2, a value which is compatible with the Do for UV inactivation of virus production by murine sarcoma-leukemia virus complex carrier cells, as reported by Yoshikura (12) . The ultraviolet dose commonly used for the XC cell assay in other laboratories reportedly varies from 1,400 ergs/mm2 to 1,800 ergs/mm2 (1, 9) . This UV dose level was reported to have no effect on plaque number in the systems tested. However, in the case of RadLV tested on BL-5 and MEF cells, this dose reduced the plaque number to 10% of the unirradiated control level. It is not yet known whether this striking sensitivity to UV is a property of the virus or of the cell lines used in these studies. 
